Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo- and Haloperidol-Controlled Double-Blind Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder

NCT00129220 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00129220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00129220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo- and Haloperidol-Controlled Double-Blind Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2005
Completion date
January 31, 2009
Enrollment
224 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder